Overview of Dr. Chakraborty
Dr. Rajshekhar Chakraborty is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine and has been in practice 9 years. He is one of 117 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032Fax+1 212-305-6891
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
University of Arkansas For Medical Sciences College of MedicineClass of 2010- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology
Certifications & Licensure
NY State Medical License 2020 - 2025
OH State Medical License 2017 - 2021
MN State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 82 citationsInterphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category.Eli Muchtar, Angela Dispenzieri, Shaji Kumar, Rhett P. Ketterling, David Dingli
Leukemia. 2017-07-01 - 23 citationsRecommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.Meera Mohan, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic
British Journal of Haematology. 2023-12-01 - 17 citationsThe changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.Lindsay Hammons, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu
Haematologica. 2024-03-01
Abstracts/Posters
- Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRajshekhar Chakraborty, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Venous thromboembolism risk with contemporary lenalidomide-based regimes for multiple myeloma: A systematic review and meta-analysis.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
